Physician profile
Scott Kurzer
NPI 1477549897
$1,593.79
in general payments reported to CMS, 2019-2025
19 companies · $20.99 in 2025
The $20.99 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $644 · 2020: $474 · 2021: $417 · 2024: $38.43 · 2025: $20.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $334.13 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $202.34 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $187.06 | 2019-2021 | |
| Novo Nordisk INC | $177.26 | 2019-2021 | |
| Abbvie INC. | $144.05 | 2020-2024 | |
| Astellas Pharma US INC | $92.00 | 2019-2020 | |
| Amarin Pharma, INC. | $87.59 | 2019-2021 | |
| Allergan, INC. | $68.72 | 2020 | |
| Lilly USA, LLC | $57.71 | 2019-2024 | Mounjaro |
| Biohaven Pharmaceuticals, INC. | $53.57 | 2021 | |
| Sanofi-Aventis U.S. LLC | $49.87 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.12 | 2019 | |
| Abbott Laboratories | $20.99 | 2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $19.38 | 2020 | |
| Eisai INC. | $17.12 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16.40 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $14.30 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.25 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Kurzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.